SCINAI IMMUNOTHERAPEUTICS LT (SCNI) Stock Price & Overview
NASDAQ:SCNI • US09073Q3039
Current stock price
The current stock price of SCNI is 0.7076 USD. Today SCNI is up by 0.37%. In the past month the price decreased by -1.72%. In the past year, price decreased by -79.19%.
SCNI Key Statistics
- Market Cap
- 2.454M
- P/E
- 0.26
- Fwd P/E
- N/A
- EPS (TTM)
- 2.75
- Dividend Yield
- N/A
SCNI Stock Performance
SCNI Stock Chart
SCNI Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to SCNI. When comparing the yearly performance of all stocks, SCNI is a bad performer in the overall market: 93.27% of all stocks are doing better.
SCNI Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to SCNI. SCNI has a bad profitability rating. Also its financial health evaluation is rather negative.
SCNI Earnings
SCNI Forecast & Estimates
SCNI Groups
Sector & Classification
SCNI Financial Highlights
Over the last trailing twelve months SCNI reported a non-GAAP Earnings per Share(EPS) of 2.75.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 728.88% | ||
| ROA | 40.51% | ||
| ROE | 61.03% | ||
| Debt/Equity | 0.04 |
SCNI Ownership
SCNI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 13.82 | 362.599B | ||
| AMGN | AMGEN INC | 15.24 | 187.489B | ||
| GILD | GILEAD SCIENCES INC | 15.52 | 170.335B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.42 | 115.33B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.68 | 77.479B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 41.84 | 41.4B | ||
| INSM | INSMED INC | N/A | 29.315B | ||
| NTRA | NATERA INC | N/A | 27.677B | ||
| BIIB | BIOGEN INC | 11.29 | 26.631B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.55 | 22.979B | ||
| MRNA | MODERNA INC | N/A | 20.292B | ||
| EXAS | EXACT SCIENCES CORP | 345.14 | 20.026B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 18.981B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SCNI
Company Profile
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Company Info
IPO: 2007-06-07
SCINAI IMMUNOTHERAPEUTICS LT
Jerusalem Biopark, 2Nd Floor, Hadassah Ein Kerem Campus
JERUSALEM IL
Employees: 31
Phone: 97289302529
SCINAI IMMUNOTHERAPEUTICS LT / SCNI FAQ
What does SCNI do?
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Can you provide the latest stock price for SCINAI IMMUNOTHERAPEUTICS LT?
The current stock price of SCNI is 0.7076 USD. The price increased by 0.37% in the last trading session.
What is the dividend status of SCINAI IMMUNOTHERAPEUTICS LT?
SCNI does not pay a dividend.
How is the ChartMill rating for SCINAI IMMUNOTHERAPEUTICS LT?
SCNI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Which stock exchange lists SCNI stock?
SCNI stock is listed on the Nasdaq exchange.
Who owns SCINAI IMMUNOTHERAPEUTICS LT?
You can find the ownership structure of SCINAI IMMUNOTHERAPEUTICS LT (SCNI) on the Ownership tab.
What is the Short Interest ratio of SCINAI IMMUNOTHERAPEUTICS LT (SCNI) stock?
The outstanding short interest for SCINAI IMMUNOTHERAPEUTICS LT (SCNI) is 6042.5% of its float.